NCT05645432View on ClinicalTrials.gov

An Open-Label Study Evaluating Brexanolone in Adults With Tinnitus

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 10, 2023

Primary Completion Date

November 21, 2023

Study Completion Date

November 21, 2023

Conditions
Tinnitus
Interventions
DRUG

Brexanolone

Brexanolone IV infusion

Trial Locations (2)

30331

Sage Investigational Site, Atlanta

52242

Sage Investigational Site, Iowa City

All Listed Sponsors
lead

Supernus Pharmaceuticals, Inc.

INDUSTRY

NCT05645432 - An Open-Label Study Evaluating Brexanolone in Adults With Tinnitus | Biotech Hunter | Biotech Hunter